Basic and Diluted Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2019

Schedule of Common Equivalent Shares were Excluded From Diluted Net Loss Per Share Calculation because their Inclusion would have been Anti-Dilutive

The following common equivalent shares were excluded from the diluted net loss per share calculation because their inclusion would have been anti-dilutive:

	Three Months Ended March 31,
	2019		2018
Stock options		1,226,906		2,717,533
Convertible senior notes		3,411,199		3,411,199
Non-vested market-based restricted stock units		—		222,626
Non-vested performance-based restricted stock units		377,896		—
Non-vested restricted stock units		676,303		445,250
Total		5,692,304		6,796,608

Schedule of Common Stock Reserved

The amount of such shares of the Company’s common stock reserved for these purposes at March 31, 2019 is as follows:

	Number of Shares
Stock options issued and outstanding		1,226,906
Nonvested RSUs		1,054,199
Additional shares available for grant under equity plans		1,859,218
Total		4,140,323